Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

A cortical neuropeptide with neuronal depressant and sleep-modulating properties.

Authors: De Lecea, L  Criado, JR  Prospero-Garcia, O  Gautvik, KM  Schweitzer, P  Danielson, PE  Dunlop, CL  Siggins, GR  Henriksen, SJ  Sutcliffe, JG 
Citation: de Lecea L, etal., Nature 1996 May 16;381(6579):242-5.
Pubmed: (View Article at PubMed) PMID:8622767
DOI: Full-text: DOI:10.1038/381242a0

Acetylcholine (ACh) plays a key role in the transitions between the different phases of sleep: Slow-wave sleep requires low ACh concentrations in the brain, whereas rapid-eye-movement (REM) sleep is associated with high levels of ACh. Also, these phases of sleep are differentially sensitive to a number of endogenous neuropeptides and cytokines, including somatostatin, which has been shown to increase REM sleep without significantly affecting other phases. Here we report the cloning and initial characterization of cortistatin, a neuropeptide that exhibits strong structural similarity to somatostatin, although it is the product of a different gene. Administration of cortistatin depresses neuronal electrical activity but, unlike somatostatin, induces low-frequency waves in the cerebral cortex and antagonizes the effects of acetylcholine on hippocampal and cortical measures of excitability. This suggests a mechanism for cortical synchronization related to sleep.


Gene Ontology Annotations
Objects Annotated

Additional Information

RGD Object Information
RGD ID: 727760
Created: 2003-11-03
Species: All species
Last Modified: 2003-11-03
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.